Mylan to launch cheaper EpiPen after political backlash

Published



Mylan is taking another stab at trying to quell the outrage over its $600 price tag for the life-saving allergy treatment EpiPen.

The generic drug company said it will sell a cheaper version of the EpiPen that will cost $300 for a two-pack carton, a 50 percent discount. Mylan’s price increase on EpiPen has sparked calls from Congress for hearings. Mylan said it will release the new product in the next few weeks.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.